Vertex Pharmaceuticals Inc (VRTX) earnings · P/E 31, rev $12.00B
These earnings events as JSON? API free 100/dayVertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US. It is led by Reshma Kewalramani FASN, M.D..
This VRTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 30.5.
When the next VRTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 8.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full VRTX research stays on the stock page; the tape stays on the quote page.
VRTX earnings FAQ
What are VRTX's latest revenue and net income?
Latest cached Vertex Pharmaceuticals Inc (VRTX) revenue for Dec 31, 2025 was $12.00B. Net income was $3.95B. Statements: https://lician.com/financials/vrtx
What is VRTX's latest diluted EPS?
Latest cached Vertex Pharmaceuticals Inc (VRTX) diluted EPS for Dec 31, 2025 was $15.32.
What period does the latest VRTX earnings print cover?
The latest cached Vertex Pharmaceuticals Inc (VRTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did VRTX revenue change from the prior cached period?
Cached Vertex Pharmaceuticals Inc (VRTX) revenue was up 8.9% from $11.02B (Dec 31, 2024) to $12.00B (Dec 31, 2025). Statements: https://lician.com/financials/vrtx
What is VRTX's P/E ratio?
Vertex Pharmaceuticals Inc (VRTX) trailing P/E is 30.5 on the latest cached fundamentals snapshot.
Where are VRTX earnings listed?
Cached earnings facts for Vertex Pharmaceuticals Inc (VRTX) are listed at https://lician.com/earnings/vrtx. Statements: https://lician.com/financials/vrtx
Not investment advice.